News
After years of bashing the medical establishment, Drs. Vinay Prasad and Marty Makary are stuck in a trap. Any attempt to ...
A large tertiary care center in Sydney, Australia is pulling out all the stops to try and cut their expenses. As of next ...
Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
4d
MedPage Today on MSNKennedy's mRNA Moves Anger MAHA Allies; Winning Back NIH Grants; Start-Up Games HSAsMary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take post-Covid, changes to the Vaccine Advisory Committee and much more.
Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.
Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and safety of COVID-19 vaccines for young children.
Wellbeing Whisper on MSN3d
Why Most Americans Will Skip COVID Boosters—and What That Means for Public HealthWe want to know more about what these products are doing,” said Dr. Vinay Prasad in a recent FDA livestreamed presentation. The statement is made as there has been a significant policy shift in the U.
For the best immunization policy, they argue, the U.S. should look to Europe. Marty Makary, the new FDA commissioner, and ...
20don MSN
Medical associations representing hundreds of thousands of doctors, medical professionals and scientists in the United States are suing the leaders of U.S. health agencies for limiting who can get ...
20d
Axios on MSNDocs sue RFK Jr. over COVID vax policy changesThe American Academy of Pediatrics and other physician groups on Monday sued HHS Secretary Robert F. Kennedy Jr. for unilaterally changing federal COVID vaccine recommendations, saying the move ...
Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results